Lantheus to Present at March 2026 Investor Conferences
BEDFORD, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced Mary Anne Heino, Executive Chairperson and Chief Executive Officer, will present at the following investor conferences.
- TD Cowen 46th Annual Health Care Conference
March 3, 2026 at 11:10 a.m. ET - Leerink Global Healthcare Conference
March 10, 2026 at 8:00 a.m. ET
A replay of the webcasts will be available on the Company’s website for at least 30 days following the live presentation.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland, and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silgan (SLGN) Has Dropped 6.2% Since Its Most Recent Earnings Report: Is a Recovery Possible?
Snap (SNAP) Rises 4.3% Following Previous Earnings Announcement: Will the Momentum Persist?
Why has Cognizant (CTSH) dropped 14.4% following its most recent earnings announcement?
Uber (UBER) Rises 0.3% Following Previous Earnings Release: Will the Momentum Last?
